The Lancet Haematology

Correction to Lancet Haematol 2025; 12: e248-57.

Pub Date : 2025-04-14 DOI: 10.1016/s2352-3026(25)00106-1

Anti-GPRC5D CAR T-cell therapy as a salvage treatment in patients with progressive multiple myeloma after anti-BCMA CAR T-cell therapy: a single-centre, single-arm, phase 2 trial.

Pub Date : 2025-04-11 DOI: 10.1016/s2352-3026(25)00048-1 Jieyun Xia,Qian Sun,Dian Zhou,Hujun Li,Ying Wang,Yuekun Qi,Jiang Cao,Zhiling Yan,Depeng Li,Hai Cheng,Wei Sang,Feng Zhu,Haiying Sun,Wei Chen,Kunming Qi,Dongmei Yan,Tingting Qiu,Tingyu Hu,Weiying Gu,Jun Qian,Fan Xia,Na Qi,Congqian Jin,Yang Liu,Xue Wang,Yanlei Zhang,Shuixiu Peng,Zhenyu Li,Alex H Chang,Kailin Xu

Sequential CAR T-cell therapy in myeloma: going from BCMA to GPRC5D.

Pub Date : 2025-04-11 DOI: 10.1016/s2352-3026(25)00074-2 Niels W C J van de Donk,Carlos Fernandez de Larrea